J B Hunt Transport Services Inc vs Novavax Inc — how do they compare? J B Hunt Transport Services Inc trades at $294.9 (market cap $27.36B), while Novavax Inc trades at $8.12 (market cap $1.30B). The key difference: J B Hunt Transport Services Inc is far larger — about 21× Novavax Inc's market cap, and J B Hunt Transport Services Inc pays a 0.62% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| JBHT | NVAX | |
|---|---|---|
Market Cap | $27.36B | $1.30B |
Sector | Industrials | Health |
52-Week High | $298.41 | $11.19 |
52-Week Low | $130.65 | $6.22 |
Enterprise Value | $28.50B | $800.50M |
Dividend Yield | 0.62% | — |
Signals from Pluang's Aura AI — not financial advice
J.B. Hunt Transport Services (JBHT) trades at $293.26, up 0.63% today, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for three consecutive quarters. Recent Q2 2026 results featured EPS of $1.91 versus $1.71 expected, driven by intermodal growth and cost discipline. Revenue for 2025 was $12.00B with a net income margin of 4.98%. Analysts maintain a Buy consensus with a $299.82 price target, citing freight market recovery and margin expansion.
The outlook for JBHT is positive, supported by structural industry shifts toward rail and efficient network operations. Investment opportunities include continued earnings momentum and potential price appreciation toward the $345 high target. Risks involve premium valuation (P/E 41.45), economic sensitivity, and competitive pressures. The stock's current level demands careful valuation assessment despite favorable fundamentals and analyst optimism.
Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.
Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.
Trailing returns across standard periods
Latest headlines on both assets
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →